Signios Biosciences
PrivateLast Round
Series E
Jul 21, 2025
Total Funding Raised
$166.5M
Company Overview
Signios Biosciences is a biotechnology company that provides an integrated end-to-end suite of multiomic technologies and an AI-driven bioinformatics platform for pharmaceutical companies, biotech firms, and academic institutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signios Biosciences Comparables
Compare Signios Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carolina Molecular | 85% | |
| Admera Health | 84% | |
| Psomagen, Inc. | 81% | |
Signios Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jul 21, 2025 | ||||
| VC Round | Aug 30, 2022 | ||||
| Series D | Apr 1, 2020 | ||||
| Series C | Mar 5, 2018 | ||||
| Series B | Jul 22, 2015 | ||||
Series A | Jun 4, 2014 |
Signios Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Housing Development Finance Corporation Limited | Series C |
| Peak XV Partners | Series C |
| Sequoia Capital | Series D, Series B |
| Emerge Ventures | Series A |
| Novo Holdings | VC Round, Series E |
| Papillon Capital | Series A |
| HDFC Asset Management | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors increased 40% MoM.
- Jul 21, 2025
$48M round led by Maj Invest and Novo Holdings.
Signios Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |